Clinical Trials Report Unveiled in Texas

03.26.13 | By

Dr. Curtis Triplett, an assistant professor of diabetes medicine at the University of Texas Health Science Center at San Antonio Texas Diabetes Institute, is a clinician on the front lines of the fight against diabetes.

IP Protection Support Strong in the Congress

03.26.13 | By

Last week Senate Finance Committee Chair, Max Baucus (D. MT), and Ranking Member Orrin Hatch (R. UT) took a strong stand urging that the Administration secure robust intellectual property (IP) standards in the Trans-Pacific Partnership (TPP). In a letter to Ambassador Demetrios Marantis, Acting U.S.

Patent Settlements

03.25.13 | By

The Supreme Court heard arguments today in the case of Federal Trade Commission v.

"Fixing Cancer"

03.25.13 | By

If we really want to "fix cancer," as Ezekiel Emanuel and a group of oncologists suggested in the New York Times this weekend, we should focus on how we can continue to build on medical innovation collaborations that can lead to better scientific knowledge and discovery of targeted treatments that can help defeat this complex disease.

Biopharmaceutical Innovation

03.22.13 By Randy Burkholder

Canada and the TPP: An IP Challange

03.04.13 By Jay Taylor

Miracle AIDS Baby - Medical Innovation at Work

03.04.13 By Mark Grayson

In Case You Missed It: Innovation's Impact

02.15.13 By Christian Clymer

Statement to State of the Union Address

WASHINGTON, D.C. (February 13, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

PhRMA and EFPIA Applaud Push for EU-US Trade Agreement

Washington, D.C. and Brussels (February 12, 2013) —The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) welcome today’s announcement of a new trade agreement that will strengthen economic ties between Europe and the United States.

Pages

Subscribe to RSS - Opinion